title: Necrotizing fasciitis in a pediatric patient treated with etanercept and cyclosporine for macrophage activation syndrome.
authors.forename: Paola Sabrina
authors.initials: PS
authors.lastname: Buonuomo
authors.forename: Andrea
authors.initials: A
authors.lastname: Campana
authors.forename: Antonella
authors.initials: A
authors.lastname: Insalaco
authors.forename: Claudia
authors.initials: C
authors.lastname: Bracaglia
authors.forename: Manuela
authors.initials: M
authors.lastname: Pardeo
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Cortis
mesh_terms: D002675:Child, Preschool; D016572:Cyclosporine / Q000009:adverse effects* / Q000627:therapeutic use; D000068800:Etanercept; D019115:Fasciitis, Necrotizing / Q000139:chemically induced*; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D055501:Macrophage Activation Syndrome / Q000188:drug therapy*; D008297:Male; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D012307:Risk Factors
chemical_list: D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D016572:Cyclosporine; D000068800:Etanercept